Sakar Healthcare Limited — Flucloxacillin Exporter Profile
Indian Pharmaceutical Exporter · #11 for Flucloxacillin · $447.2K export value · DGFT Verified
Sakar Healthcare Limited is the #11 Indian exporter of Flucloxacillin with $447.2K in export value and 32 verified shipments. Sakar Healthcare Limited holds a 1.2% market share in Flucloxacillin exports across 5 countries. The company exports 6 pharmaceutical products worth $16.0M across 4 therapeutic categories.
Sakar Healthcare Limited — Flucloxacillin Export Profile: Buyers & Destinations
Where Does Sakar Healthcare Limited Export Flucloxacillin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MYANMAR | $270.3K | 15 | 60.3% |
| CAMEROON | $113.2K | 12 | 25.3% |
| THAILAND | $43.3K | 2 | 9.7% |
| MOZAMBIQUE | $15.6K | 3 | 3.5% |
| MALAWI | $5.6K | 1 | 1.3% |
Sakar Healthcare Limited exports Flucloxacillin to 5 countries. The largest destination is MYANMAR accounting for 60.3% of Sakar Healthcare Limited's Flucloxacillin shipments, followed by CAMEROON (25.3%) and THAILAND (9.7%). These destinations reflect Sakar Healthcare Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Flucloxacillin from Sakar Healthcare Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M/S. ROYAL DISTRIBUTION CO. LTD. | MYANMAR | $95.0K | 4 |
| M/S. PHARMA-ROC S.A.R.L. REPARTITEU | CAMEROON | $56.2K | 9 |
| ROYAL DISTRIBUTION CO. LTD. | MYANMAR | $56.1K | 6 |
| ROYAL DISTRIBUTION CO LIMITED | MYANMAR | $50.0K | 1 |
| ROYAL DISTRIBUTION CO. LIMITED | MYANMAR | $50.0K | 1 |
| NSD TRADING CO LTD | THAILAND | $43.3K | 2 |
| PHARMA-ROC S.A.R.L. REPARTITEUR | CAMEROON | $37.0K | 2 |
| PHARMA ROC S A R L REPARTITEU | CAMEROON | $20.0K | 1 |
| ROYAL DISTRIBUTION CO LTD | MYANMAR | $19.1K | 3 |
| PHARMACHEMIE LTD | MOZAMBIQUE | $6.4K | 1 |
Sakar Healthcare Limited supplies Flucloxacillin to 12 buyers globally. The largest buyer is M/S. ROYAL DISTRIBUTION CO. LTD. (MYANMAR), followed by M/S. PHARMA-ROC S.A.R.L. REPARTITEU (CAMEROON) and ROYAL DISTRIBUTION CO. LTD. (MYANMAR). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Flucloxacillin Export Value and How Much Does Sakar Healthcare Limited Contribute?
India exported $30.0M worth of Flucloxacillin through 1,146 shipments from 123 suppliers to 44 countries, serving 198 buyers globally. Sakar Healthcare Limited contributes $447.2K to this total, accounting for 1.2% of India's Flucloxacillin exports. Sakar Healthcare Limited ships Flucloxacillin to 5 countries through 12 buyers.
What Is the Average Shipment Value for Sakar Healthcare Limited's Flucloxacillin Exports?
Sakar Healthcare Limited's average Flucloxacillin shipment value is $14.0K per consignment, based on 32 shipments totaling $447.2K. The largest destination is MYANMAR (60.3% of Sakar Healthcare Limited's Flucloxacillin exports).
How Does Sakar Healthcare Limited Compare to Other Indian Flucloxacillin Exporters?
Sakar Healthcare Limited ranks #11 among 123 Indian Flucloxacillin exporters with a 1.2% market share. The top 3 exporters are MEDREICH LIMITED ($16.9M), MICRO LABS LIMITED ($4.0M), AUROBINDO PHARMA LTD ($1.7M). Sakar Healthcare Limited processed 32 shipments to 5 destination countries.
What Flucloxacillin Formulations Does Sakar Healthcare Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMOXICILLIN AND FLUCLOXACILLIN CAPSULE 2 | $64.0K | 2 |
| AMOXYCILLIN & FLUCLOXACILLIN CAPSULES SUPRAMOX DRY SYRUP AS PER DOCUMENT | $50.0K | 1 |
| AMOXICILLIN AND FLUCLOXACILLIN CAPSULES(SUPRAMOX CAPSULE) | $50.0K | 1 |
| AMOXICILLIN AND FLUCLOXACILLIN CAPSULES(SUPRAMOX CAPSULE)NOS | $42.0K | 3 |
| AMOXYCILLIN & FLUCLOXACILLIN FOR ORAL SU | $31.1K | 2 |
| SUPRAMOX CAPSULE AMOXICILLIN AND FLUCLOXACILLIN CAPSULES | $28.3K | 1 |
| FLUCLOX 500 - CAMEROON ( FLUCLOXACILLINCAPSULES BP 500 MG.) | $26.9K | 3 |
| FLUCLOXACILLIN CAPSULES BP 500 MG. ( FLUCLOX 500) BATCH NO.: C25202, MFG: 03-2025, EXP: 02-2027 | $22.8K | 1 |
| FLUCLOXACILLIN CAPSULES BP 500 MG.(FLUCLOX 500) BATCH NO.: C23209 MFG: 06-2023 EXP: 05-2025 (ASPERINV) | $20.0K | 1 |
| FLUCLOX 500 (FLUCLOXACILLIN CAPSULES BP500 MG) BATCH: C24203, MFG: 01-2024, EXP: 12-2025NOS | $18.0K | 3 |
Sakar Healthcare Limited exports 21 distinct Flucloxacillin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMOXICILLIN AND FLUCLOXACILLIN CAPSULE 2 with 2 shipments worth $64.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Sakar Healthcare Limited Compare to Nearest Flucloxacillin Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | AUROBINDO PHARMA LIMITED | $639.9K | 22 | 1 | $29.1K |
| 10 | MEDOPHARM PRIVATE LIMITED | $499.9K | 25 | 5 | $20.0K |
| 11 | SAKAR HEALTHCARE LIMITED ★ | $447.2K | 32 | 5 | $14.0K |
| 12 | MILAN LABORATORIES INDIA PRIVATE LIMITED | $350.0K | 7 | 2 | $50.0K |
| 13 | SCOTT EDIL PHARMACIA LIMITED | $320.4K | 22 | 9 | $14.6K |
Sakar Healthcare Limited ranks #11 among 123 Indian Flucloxacillin exporters. Average shipment value of $14.0K compared to the market average of $243.5K. The closest competitors by value are AUROBINDO PHARMA LIMITED and MEDOPHARM PRIVATE LIMITED.
Which Indian Ports Ship Flucloxacillin Exports?
| Port | Shipments | % Share |
|---|---|---|
| BANGALORE ICD | 140 | 12.2% |
| BANGALORE ICD (INWFD6) | 107 | 9.3% |
| NHAVA SHEVA SEA (INNSA1) | 100 | 8.7% |
| JNPT | 76 | 6.6% |
| BANGALORE ACC (INBLR4) | 69 | 6.0% |
| JNPT/ NHAVA SHEVA SEA | 55 | 4.8% |
| SAHAR AIR | 50 | 4.4% |
| BANGALORE AIR | 36 | 3.1% |
What Other Advanced Antibiotics Products Does Sakar Healthcare Limited Export?
Sakar Healthcare Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Sakar Healthcare Limited's Flucloxacillin Exports
Sakar Healthcare's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have disrupted Red Sea shipping routes, leading to increased freight costs and potential delays. The Pharmaceuticals Export Promotion Council of India estimates that the domestic pharma industry could face losses between ₹2,500 crore and ₹5,000 crore due to these disruptions. (medicaldialogues.in) As a company with significant export activities, Sakar may need to explore alternative logistics strategies to mitigate these challenges.
In the United States, recent tariff policies have introduced uncertainties for Indian pharmaceutical exporters. While health products have been exempt from U.S. tariffs, there have been threats to impose significant increases to encourage domestic production. This situation necessitates vigilance from companies like Sakar to adapt to potential policy shifts. (lemonde.fr)
European Union regulatory changes, such as the Falsified Medicines Directive, impose stringent compliance requirements on pharmaceutical imports. Sakar's recent marketing authorizations in Europe suggest a proactive approach to meeting these standards, enhancing its competitiveness in the EU market. (prysm.fi)
Sakar Healthcare Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is crucial for Indian pharmaceutical exporters. Sakar Healthcare's successful acquisition of marketing authorizations in Europe indicates adherence to Good Manufacturing Practices (GMP) and other regulatory requirements. Additionally, the company's development of in-house APIs and obtaining Written Confirmations reflect a commitment to quality and regulatory compliance. (prysm.fi)
About Sakar Healthcare Limited
Sakar Healthcare Limited exports 6 products worth $16.0M. Beyond Flucloxacillin, top products include Cefixime, Ceftriaxone, Heparin, Dexamethasone, Diazepam. View the complete Sakar Healthcare Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Flucloxacillin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Flucloxacillin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sakar Healthcare Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 33 individual customs records matching Sakar Healthcare Limited exporting Flucloxacillin, covering 21 formulations to 5 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 44+ countries, 198+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Flucloxacillin Export Data from Sakar Healthcare Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sakar Healthcare Limited's Flucloxacillin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sakar Healthcare Limited
Full Company Profile →
6 products · $16.0M total trade · 4 categories
Flucloxacillin Stats
Company Overview
Top Products by Sakar Healthcare Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sakar Healthcare Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Flucloxacillin. For current shipment-level data, contact TransData Nexus.